Li Jian-Yong

31PUBLICATIONS
75CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMedical biotechnology not elsewhere classifiedHaematologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jun 02, 2026
Concurrent antiviral-immunochemotherapy strategy safely overcomes high hepatitis B viral load barrier in diffuse large B-cell lymphoma: A multicentre cohort study.

|Apr 26, 2026
Outcomes With First-Line PD1 Inhibitors in Extranodal NK/T-Cell Lymphoma: A Comparative Analysis From a 755-Patient Multicenter Cohort.

|Mar 09, 2026
A single-center retrospective study suggests a potential benefit of BTK inhibitor-based therapy in patients with histologic transformation of Waldenström macroglobulinemia.

Yi Xia, Haorui Shen, Yi Miao

|Feb 27, 2026
Association between body mass index and outcomes in lymphoma-associated haemophagocytic lymphohistiocytosis: A retrospective multicentre cohort study of Jiangsu Cooperative Lymphoma Group (JCLG).

Yanping Liu, Jing Zhang, Ling Wang

|Feb 11, 2026
Penpulimab combined with rituximab, high-dose methotrexate, and cytarabine (Pen-RMA) in newly diagnosed primary central nervous system lymphoma (PCNSL): a phase 2 trial.

Hao-Rui Shen, Jia-Zhu Wu, Hua Yin

|Sep 08, 2025
Endothelial Activation and Stress Index Serves as a Predictor for Survival in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis: A Retrospective Multicenter Cohort Study of Jiangsu Cooperative Lymphoma Group.

Yanping Liu, Yimin Ren, Ling Gao

Pageof 6

Frequent Collaborators

12 joint publications

Lei Fan

8 joint publications

Yi Miao

7 joint publications

Wei Xu

5 joint publications

Yi Xia